全球领先的生物制药行业供应商Avantor®宣布对其Masterflex®产品组合进行全面整合，旨在打造贯穿研发至生物工艺制造全流程的一体化流体管理解决方案。此次战略调整将打破传统分段式管理模式，通过标准化接口与智能化系统的协同，显著提升流体传输过程的精确度与可追溯性。
整合后的Masterflex®系列将涵盖从实验室规模蠕动泵到工业级生物反应器配套系统的完整产品矩阵，使研究人员能够无缝衔接实验数据与规模化生产参数。该举措不仅缩短了工艺开发周期，更通过模块化设计降低了设备维护成本，为生物制药企业构建了从概念验证到商业化生产的数字化桥梁。
随着全球生物制药行业对生产效率和合规性要求的不断提升，Avantor®此次产品线优化展现了其对行业痛点的精准把握。通过统一技术标准与服务体系，企业可在流体管理环节实现约30%的操作效率提升，同时满足FDA等监管机构对数据完整性的严苛要求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.